A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder

Biological Psychiatry

Volumn 73, Issue 1, 2013, Pages 24-31

  Brennan, Brian P ^a,b   Rauch, Scott L ^a,b   Jensen, J Eric ^a,b   Pope Jr , Harrison G ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Choline; glutamate; magnetic resonance spectroscopy; N acetylaspartate; obsessive compulsive disorder; OCD

Indexed keywords

GLUTAMINE; GLYCINE; N ACETYLASPARTIC ACID; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ANTERIOR CINGULATE; BASAL GANGLION; COGNITIVE THERAPY; HIPPOCAMPUS; HUMAN; NEUROIMAGING; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; THALAMUS; WHITE MATTER;

BRAIN; FUNCTIONAL NEUROIMAGING; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OBSESSIVE-COMPULSIVE DISORDER;

EID: 84870716973     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.06.023     Document Type: Review

References (100)

1. A.M. Ruscio, D.J. Stein, W.T. Chiu, R.C. Kessler The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication Mol Psychiatry 15 2010 53 63
2. M.A. Jenike Clinical practice Obsessive-compulsive disorder N Engl J Med 350 2004 259 265
3. S.E. Stewart, D.A. Geller, M. Jenike, D. Pauls, D. Shaw, B. Mullin Long-term outcome of pediatric obsessive-compulsive disorder: A meta-analysis and qualitative review of the literature Acta Psychiatr Scand 110 2004 4 13
4. M.C. Rosario-Campos, J.F. Leckman, M.T. Mercadante, R.G. Shavitt, H.S. Prado, P. Sada Adults with early-onset obsessive-compulsive disorder Am J Psychiatry 158 2001 1899 1903
5. S. Saxena, S.L. Rauch Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder Psychiatr Clin North Am 23 2000 563 586
6. L.R. Baxter Jr, M.E. Phelps, J.C. Mazziotta, B.H. Guze, J.M. Schwartz, C.E. Selin Local cerebral glucose metabolic rates in obsessive-compulsive disorder A comparison with rates in unipolar depression and in normal controls Arch Gen Psychiatry 44 1987 211 218
7. T.E. Nordahl, C. Benkelfat, W.E. Semple, M. Gross, A.C. King, R.M. Cohen Cerebral glucose metabolic rates in obsessive compulsive disorder Neuropsychopharmacology 2 1989 23 28
8. S.E. Swedo, M.B. Schapiro, C.L. Grady, D.L. Cheslow, H.L. Leonard, A. Kumar Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder Arch Gen Psychiatry 46 1989 518 523
9. C.M. Adler, P. McDonough-Ryan, K.W. Sax, S.K. Holland, S. Arndt, S.M. Strakowski fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder J Psychiatr Res 34 2000 317 324
10. H.C. Breiter, S.L. Rauch, K.K. Kwong, J.R. Baker, R.M. Weisskoff, D.N. Kennedy Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder Arch Gen Psychiatry 53 1996 595 606
11. S.L. Rauch, M.A. Jenike, N.M. Alpert, L. Baer, H.C. Breiter, C.R. Savage Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography Arch Gen Psychiatry 51 1994 62 70
12. L.R. Baxter Jr, J.M. Schwartz, K.S. Bergman, M.P. Szuba, B.H. Guze, J.C. Mazziotta Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder Arch Gen Psychiatry 49 1992 681 689
13. C. Benkelfat, T.E. Nordahl, W.E. Semple, A.C. King, D.L. Murphy, R.M. Cohen Local cerebral glucose metabolic rates in obsessive-compulsive disorder Patients treated with clomipramine Arch Gen Psychiatry 47 1990 840 848
14. S. Saxena, A.L. Brody, M.L. Ho, S. Alborzian, K.M. Maidment, N. Zohrabi Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression Arch Gen Psychiatry 59 2002 250 261
15. S.E. Swedo, P. Pietrini, H.L. Leonard, M.B. Schapiro, D.C. Rettew, E.L. Goldberger Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder Revisualization during pharmacotherapy Arch Gen Psychiatry 49 1992 690 694
16. O.A. van den Heuvel, D.J. Veltman, H.J. Groenewegen, R.J. Dolan, D.C. Cath, R. Boellaard Amygdala activity in obsessive-compulsive disorder with contamination fear: A study with oxygen-15 water positron emission tomography Psychiatry Res 132 2004 225 237
17. J.S. Kwon, J.J. Kim, D.W. Lee, J.S. Lee, D.S. Lee, M.S. Kim Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder Psychiatry Res 122 2003 37 47
18. J.R. Moffett, B. Ross, P. Arun, C.N. Madhavarao, A.M. Namboodiri N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology Prog Neurobiol 81 2007 89 131
19. J.T. Coyle The nagging question of the function of N- acetylaspartylglutamate Neurobiol Dis 4 1997 231 238
20. V. Govindaraju, K. Young, A.A. Maudsley Proton NMR chemical shifts and coupling constants for brain metabolites NMR Biomed 13 2000 129 153
21. C. Yüksel, D. Öngür Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders Biol Psychiatry 68 2010 785 794
22. D. Ebert, O. Speck, A. Konig, M. Berger, J. Hennig, F. Hohagen 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: Evidence for neuronal loss in the cingulate gyrus and the right striatum Psychiatry Res 74 1997 173 176
23. R. Bartha, M.B. Stein, P.C. Williamson, D.J. Drost, R.W. Neufeld, T.J. Carr A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects Am J Psychiatry 155 1998 1584 1591
24. M.A. Mohamed, M.A. Smith, M.W. Schlund, G. Nestadt, P.B. Barker, R. Hoehn-Saric Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: A pilot investigation comparing treatment responders and non-responders Psychiatry Res 156 2007 175 179
25. M. Yücel, B.J. Harrison, S.J. Wood, A. Fornito, R.M. Wellard, J. Pujol Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder Arch Gen Psychiatry 64 2007 946 955
26. S. Sumitani, M. Harada, H. Kubo, T. Ohmori Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients Psychiatry Res 154 2007 85 92
27. L. Besiroglu, M. Sozen, O. Ozbebit, S. Avcu, Y. Selvi, A. Bora The involvement of distinct neural systems in patients with obsessive-compulsive disorder with autogenous and reactive obsessions Acta Psychiatr Scand 124 2011 141 151
28. J.H. Jang, J.S. Kwon, D.P. Jang, W.J. Moon, J.M. Lee, T.H. Ha A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder Am J Psychiatry 163 2006 1202 1207
29. K.D. Fitzgerald, G.J. Moore, L.A. Paulson, C.M. Stewart, D.R. Rosenberg Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder Biol Psychiatry 47 2000 174 182
30. M. Atmaca, H. Yildirim, H. Ozdemir, M. Koc, S. Ozler, E. Tezcan Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder Psychiatry Clin Neurosci 63 2009 486 490
31. M. Yücel, S.J. Wood, R.M. Wellard, B.J. Harrison, A. Fornito, J. Pujol Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder Aust N Z J Psychiatry 42 2008 467 477
32. Q. Fan, L. Tan, C. You, J. Wang, C.A. Ross, X. Wang Increased N-Acetylaspartate/creatine ratio in the medial prefrontal cortex among unmedicated obsessive-compulsive disorder patients Psychiatry Clin Neurosci 64 2010 483 490
33. J. O'Neill, J.C. Piacentini, S. Chang, J.G. Levitt, M. Rozenman, L. Bergman MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder Prog Neuropsychopharmacol Biol Psychiatry 36 2012 161 168
34. A. Russell, B. Cortese, E. Lorch, J. Ivey, S.P. Banerjee, G.J. Moore Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder J Child Adolesc Psychopharmacol 13 suppl 1 2003 S31 S38
35. S.P. Whiteside, J.D. Port, B.J. Deacon, J.S. Abramowitz A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety Psychiatry Res 146 2006 137 147
36. S.P. Whiteside, J.S. Abramowitz, J.D. Port The effect of behavior therapy on caudate N-acetyl-l-aspartic acid in adults with obsessive-compulsive disorder Psychiatry Res 201 2012 10 16
37. G.J. Moore, F.P. MacMaster, C. Stewart, D.R. Rosenberg Case study: Caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder J Am Acad Child Adolesc Psychiatry 37 1998 663 667
38. J. Bolton, G.J. Moore, S. MacMillan, C.M. Stewart, D.R. Rosenberg Case study: Caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD J Am Acad Child Adolesc Psychiatry 40 2001 903 906
39. N.R. Benazon, G.J. Moore, D.R. Rosenberg Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy J Am Acad Child Adolesc Psychiatry 42 2003 1279 1285
40. D.R. Rosenberg, Y. Mirza, A. Russell, J. Tang, J.M. Smith, S.P. Banerjee Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls J Am Acad Child Adolesc Psychiatry 43 2004 1146 1153
41. P.D. Arnold, F.P. Macmaster, M.A. Richter, G.L. Hanna, T. Sicard, E. Burroughs Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder Psychiatry Res 172 2009 136 139
42. D.R. Rosenberg, F.P. MacMaster, M.S. Keshavan, K.D. Fitzgerald, C.M. Stewart, G.J. Moore Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine J Am Acad Child Adolesc Psychiatry 39 2000 1096 1103
43. G. Starck, M. Ljungberg, M. Nilsson, L. Jonsson, S. Lundberg, T. Ivarsson A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: Relationship between metabolite concentrations and symptom severity J Neural Transm 115 2008 1051 1062
44. L. Lázaro, N. Bargallo, S. Andres, C. Falcon, A. Morer, C. Junque Proton magnetic resonance spectroscopy in pediatric obsessive-compulsive disorder: Longitudinal study before and after treatment Psychiatry Res 201 2012 17 24
45. D.R. Rosenberg, A. Amponsah, A. Sullivan, S. MacMillan, G.J. Moore Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging J Child Neurol 16 2001 636 641
46. E.A. Smith, A. Russell, E. Lorch, S.P. Banerjee, M. Rose, J. Ivey Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: A magnetic resonance spectroscopy study Biol Psychiatry 54 2003 1399 1405
47. H. Kitamura, T. Shioiri, T. Kimura, M. Ohkubo, T. Nakada, T. Someya Parietal white matter abnormalities in obsessive-compulsive disorder: A magnetic resonance spectroscopy study at 3-Tesla Acta Psychiatr Scand 114 2006 101 108
48. Y. Mirza, J. O'Neill, E.A. Smith, A. Russell, J.M. Smith, S.P. Banerjee Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls J Child Neurol 21 2006 106 111
49. G. Tsai, J.T. Coyle N-acetylaspartate in neuropsychiatric disorders Prog Neurobiol 46 1995 531 540
50. J. Radua, D. Mataix-Cols Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder Br J Psychiatry 195 2009 393 402
51. J.Y. Rotge, D. Guehl, B. Dilharreguy, J. Tignol, B. Bioulac, M. Allard Meta-analysis of brain volume changes in obsessive-compulsive disorder Biol Psychiatry 65 2009 75 83
52. J. Radua, O.A. van den Heuvel, S. Surguladze, D. Mataix-Cols Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders Arch Gen Psychiatry 67 2010 701 711
53. D. Robinson, H. Wu, R.A. Munne, M. Ashtari, J.M. Alvir, G. Lerner Reduced caudate nucleus volume in obsessive-compulsive disorder Arch Gen Psychiatry 52 1995 393 398
54. D.R. Rosenberg, M.S. Keshavan, K.M. O'Hearn, E.L. Dick, W.W. Bagwell, A.B. Seymour Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder Arch Gen Psychiatry 54 1997 824 830
55. R.A. Edden, M.G. Pomper, P.B. Barker In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla Magn Reson Med 57 2007 977 982
56. C. Pittenger, M.H. Bloch, K. Williams Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment Pharmacol Ther 132 2011 314 332
57. N.R. Sibson, J. Shen, G.F. Mason, D.L. Rothman, K.L. Behar, R.G. Shulman Functional energy metabolism: in vivo 13C-NMR spectroscopy evidence for coupling of cerebral glucose consumption and glutamatergic neuronalactivity Dev Neurosci 20 1998 321 330
58. M.J. Bedard, S. Chantal Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: The importance of considering subclinical symptoms of anxiety and depression Psychiatry Res 192 2011 45 54
59. J.M. Welch, J. Lu, R.M. Rodriguiz, N.C. Trotta, J. Peca, J.D. Ding Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice Nature 448 2007 894 900
60. J.T. Ting, G. Feng Glutamatergic synaptic dysfunction and obsessive-compulsive disorder Curr Chem Genomics 2 2008 62 75
61. B.L. Miller, L. Chang, R. Booth, T. Ernst, M. Cornford, D. Nikas In vivo 1H MRS choline: Correlation with in vitro chemistry/histology Life Sci 58 1996 1929 1935
62. E. Hattingen, J. Magerkurth, U. Pilatus, A. Hubers, M. Wahl, U. Ziemann Combined (1)H and (31)P spectroscopy provides new insights into the pathobiochemistry of brain damage in multiple sclerosis NMR Biomed 24 2011 536 546
63. D.J. Meyerhoff, S. MacKay, J.M. Constans, D. Norman, C. Van Dyke, G. Fein Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging Ann Neurol 36 1994 40 47
64. B.G. Jenkins, W.J. Koroshetz, M.F. Beal, B.R. Rosen Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy Neurology 43 1993 2689 2695
65. D.L. Arnold, P.M. Matthews, G.S. Francis, J. O'Connor, J.P. Antel Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques Ann Neurol 31 1992 235 241
66. P.A. Cannistraro, N. Makris, J.D. Howard, M.M. Wedig, S.M. Hodge, S. Wilhelm A diffusion tensor imaging study of white matter in obsessive-compulsive disorder Depress Anxiety 24 2007 440 446
67. P.R. Szeszko, B.A. Ardekani, M. Ashtari, A.K. Malhotra, D.G. Robinson, R.M. Bilder White matter abnormalities in obsessive-compulsive disorder: A diffusion tensor imaging study Arch Gen Psychiatry 62 2005 782 790
68. S.Y. Yoo, J.H. Jang, Y.W. Shin, D.J. Kim, H.J. Park, W.J. Moon White matter abnormalities in drug-naive patients with obsessive-compulsive disorder: A diffusion tensor study before and after citalopram treatment Acta Psychiatr Scand 116 2007 211 219
69. S.E. Stewart, J. Platko, J. Fagerness, J. Birns, E. Jenike, J.W. Smoller A genetic family-based association study of OLIG2 in obsessive-compulsive disorder Arch Gen Psychiatry 64 2007 209 214
70. K. Ohara, H. Isoda, Y. Suzuki, Y. Takehara, M. Ochiai, H. Takeda Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder Psychiatry Res 92 1999 83 91
71. A.A. Capizzano, R.E. Jorge, L.C. Acion, R.G. Robinson In vivo proton magnetic resonance spectroscopy in patients with mood disorders: A technically oriented review J Magn Reson Imaging 26 2007 1378 1389
72. A. Yildiz-Yesiloglu, D.P. Ankerst Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: A meta-analysis Psychiatry Res 147 2006 1 25
73. S.J. Mathew, X. Mao, J.D. Coplan, E.L. Smith, H.A. Sackeim, J.M. Gorman Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: A proton magnetic resonance spectroscopic imaging study Am J Psychiatry 161 2004 1119 1121
74. M.A. Frye, J. Watzl, S. Banakar, J. O'Neill, J. Mintz, P. Davanzo Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression Neuropsychopharmacology 32 2007 2490 2499
75. D. Öngür, A.P. Prescot, J.E. Jensen, B.M. Cohen, P.F. Renshaw Creatine abnormalities in schizophrenia and bipolar disorder Psychiatry Res 172 2009 44 48
76. N. Schuff, F. Ezekiel, A.C. Gamst, D.L. Amend, A.A. Capizzano, A.A. Maudsley Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging Magn Reson Med 45 2001 899 907
77. D. Mataix-Cols, M.C. Rosario-Campos, J.F. Leckman A multidimensional model of obsessive-compulsive disorder Am J Psychiatry 162 2005 228 238
78. K. Koch, G. Wagner, C. Schachtzabel, C. Christoph Schultz, T. Straube, D. Gullmar White matter structure and symptom dimensions in obsessive-compulsive disorder J Psychiatr Res 46 2012 264 270
79. A.R. Gilbert, D. Mataix-Cols, J.R. Almeida, N. Lawrence, J. Nutche, V. Diwadkar Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study J Affect Disord 109 2008 117 126
80. D. Mataix-Cols, S. Wooderson, N. Lawrence, M.J. Brammer, A. Speckens, M.L. Phillips Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder Arch Gen Psychiatry 61 2004 564 576
81. A.R. Gilbert, D. Akkal, J.R. Almeida, D. Mataix-Cols, C. Kalas, B. Devlin Neural correlates of symptom dimensions in pediatric obsessive-compulsive disorder: A functional magnetic resonance imaging study J Am Acad Child Adolesc Psychiatry 48 2009 936 944
82. Y.Y. Shugart, Y. Wang, J.F. Samuels, M.A. Grados, B.D. Greenberg, J.A. Knowles A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families Am J Med Genet B Neuropsychiatr Genet 150B 2009 886 892
83. S.E. Stewart, J.A. Fagerness, J. Platko, J.W. Smoller, J.M. Scharf, C. Illmann Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder Am J Med Genet B Neuropsychiatr Genet 144B 2007 1027 1033
84. P.D. Arnold, T. Sicard, E. Burroughs, M.A. Richter, J.L. Kennedy Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder Arch Gen Psychiatry 63 2006 769 776
85. D.E. Dickel, J. Veenstra-VanderWeele, N.J. Cox, X. Wu, D.J. Fischer, M. Van Etten-Lee Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder Arch Gen Psychiatry 63 2006 778 785
86. J. Samuels, Y. Wang, M.A. Riddle, B.D. Greenberg, A.J. Fyer, J.T. McCracken Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder Am J Med Genet B Neuropsychiatr Genet 156B 2011 472 477
87. J.R. Wendland, P.R. Moya, K.R. Timpano, A.P. Anavitarte, M.R. Kruse, M.G. Wheaton A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder Arch Gen Psychiatry 66 2009 408 416
88. J.E. Jensen, S.C. Licata, D. Öngür, S.D. Friedman, A.P. Prescot, M.E. Henry Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMA-simulated basis sets at 4 Tesla NMR Biomed 22 2009 762 769
89. B.P. Brennan, J.I. Hudson, J.E. Jensen, J. McCarthy, J.L. Roberts, A.P. Prescot Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole Neuropsychopharmacology 35 2010 834 846
90. K. Kanamori, B.D. Ross, R.W. Kondrat Glial uptake of neurotransmitter glutamate from the extracellular fluid studied in vivo by microdialysis and (13)C NMR J Neurochem 83 2002 682 695
91. U.E. Emir, S. Raatz, S. McPherson, J.S. Hodges, C. Torkelson, P. Tawfik Noninvasive quantification of ascorbate and glutathione concentration in the elderly human brain NMR Biomed 24 2011 888 894
92. P.J. Pouwels, J. Frahm Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS NMR Biomed 10 1997 73 78
93. N. Orhan, C.I. Kucukali, U. Cakir, N. Seker, M. Aydin Genetic variants in nuclear-encoded mitochondrial proteins are associated with oxidative stress in obsessive compulsive disorders J Psychiatr Res 46 2012 212 218
94. M. Guldenpfennig, W. Wolmarans de, J.L. du Preez, D.J. Stein, B.H. Harvey Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse Physiol Behav 103 2011 404 411
95. S. Selek, H. Herken, M. Bulut, M.F. Ceylan, H. Celik, H.A. Savas Oxidative imbalance in obsessive compulsive disorder patients: A total evaluation of oxidant-antioxidant status Prog Neuropsychopharmacol Biol Psychiatry 32 2008 487 491
96. A. Nieoullon, B. Canolle, F. Masmejean, B. Guillet, P. Pisano, S. Lortet The neuronal excitatory amino acid transporter EAAC1/EAAT3: Does it represent a major actor at the brain excitatory synapse? J Neurochem 98 2006 1007 1018
97. K. Aoyama, S.W. Suh, A.M. Hamby, J. Liu, W.Y. Chan, Y. Chen Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse Nat Neurosci 9 2006 119 126
98. J.E. Jensen, B. Frederick Bde, P.F. Renshaw Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging NMR Biomed 18 2005 570 576
99. A.S. Sampaio, J. Fagerness, J. Crane, M. Leboyer, R. Delorme, D.L. Pauls Association between polymorphisms in GRIK2 gene and obsessive-compulsive disorder: A family-based study CNS Neurosci Ther 17 2011 141 147
100. P.D. Arnold, D.R. Rosenberg, E. Mundo, S. Tharmalingam, J.L. Kennedy, M.A. Richter Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: A preliminary study Psychopharmacology (Berl) 174 2004 530 538